With Control Resonant on everyone’s mind, Remedy decided to drop a nice little bit of news regarding Alan Wake II. After finally beginning to turn a profit last February, the survival horror title has now eclipsed 3 million in sales across PC and consoles.
Per Remedy’s half-year financial report, the long-awaited sequel to the 2010 original reached the three million mark “at an expected pace.” The other titles in the franchise, including 2021’s Alan Wake Remastered, also sold at a normal rate.
“In the second quarter, royalties from both titles were generated entirely by consumer sales and there were no platform deal accruals. Alan Wake 2‘s lifetime sales exceeded 3 million copies during Q2.”
The blemish for Remedy was a decline in game sales and royalties mainly caused by FBC: Firebreak’s launch. In the second quarter, most of FBC: Firebreak’s sales were “revenue accruals from subscription service agreements.”
Obviously, Remedy is currently working towards the September release of Control Resonant, which the company believes will be one of the major releases this year.
“As of August 11th, 2026, we have over 1.5 million wishlists across platforms. Pre-orders opened with healthy momentum, and our data indicates the game is tracking well against comparable titles in its launch window. We are seeing positive traction both in our traditional and growth markets. During the campaign window after the pre-order announcement, on PlayStation, our analytics show Control Resonant ranking among the top three pre-ordered games in the US, Germany and Brazil. It has been encouraging to see Remedy’s voice resonate broadly with players as we advance in our self-publishing strategy.”
Control Resonant launches September 24 for PlayStation 5, Xbox Series, PC via Steam and Epic Games Store. Alan Wake II is available now on PC via the Epic Games Store, PlayStation 5 and the Xbox Series.